![Joseph deBethizy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph deBethizy
Directeur/Membre du Conseil chez
ARGENX SE
Fortune : 2 M $ au 31/05/2026
Profil
Joseph Donald deBethizy was the founder of Targacept, Inc. (1997) and served as President, Chief Executive Officer & Director from 2011 to 2012.
Current jobs include Vice Chairman at argenx SE since 2023, Chairman at Albumedix A since 2016, Chairman at Saniona A, Chairman at Sartorius Albumedix Ltd., Director at Proterris, Inc. since 2013, Director at Lophora ApS since 2021, Member-Supervisory Board at NOXXON Pharma AG, President at White City Consulting ApS since 2014, and President at Innovent LLC.
Former jobs include President, Chief Executive Officer & Director at Roche Innovation Center Copenhagen A in 2014, President & Chief Executive Officer at Roche Innovation Center Copenhagen A, Executive Chairman at Contera Pharma ApS from 2013 to 2014, Chairman at Rigontec GmbH from 2015 to 2017, Director at Biotechnology Innovation Organization, Director at BioSource, Inc., Director at Cereno Scientific AB, Director at The North Carolina Biotechnology Center, Director at LigoCyte Pharmaceuticals, Inc., Director at Serendex Pharmaceuticals A from 2015 to 2016, Independent Director at Asceneuron SA, Independent Director at Saniona AB in 2022, Director at EnBiotix, Inc., Independent Non-Executive Director at Newron Pharmaceuticals SpA from 2014 to 2023, Managing Director at Albumin Holding ApS, Director at Rigontec GmbH from 2015 to 2017, Adjunct Professor at Duke University, Adjunct Professor at Wake Forest University, and Member-Supervisory Board at TME Pharma NV from 2019 to 2021.
Education includes an undergraduate degree from the University of Maryland and graduate and doctorate degrees from Utah State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/02/2026 | 2 465 ( 0% ) | 2 M $ | 31/05/2026 |
Postes actifs de Joseph deBethizy
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur/Membre du Conseil | 13/05/2015 |
Lophora ApS | Directeur/Membre du Conseil | 01/01/2021 |
Albumedix Ltd.
 Albumedix Ltd. BiotechnologyHealth Technology Manufactures drugs, cell therapies and vaccines | Président | - |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Président | - |
Proterris, Inc.
 Proterris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures applications of low-dose carbon monoxide | Directeur/Membre du Conseil | 01/01/2013 |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Président | 01/01/2016 |
Innovent LLC | President | - |
White City Consulting ApS | President | 01/09/2014 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Directeur/Membre du Conseil | - |
Anciens postes connus de Joseph deBethizy
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Joseph deBethizy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioSource, Inc.
 BioSource, Inc. Medical SpecialtiesHealth Technology Develops computerized screening devices used to scan the entire body for early detection of irregularities | Health Technology |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah State University
 Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
LigoCyte Pharmaceuticals, Inc.
 LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceuticals specifically for respiratory conditions | Health Technology |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of patients | Health Technology |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases | Health Technology |
White City Consulting ApS | |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Albumedix A/S
Albumedix A/S Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Innovent LLC | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Proterris, Inc.
Proterris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures applications of low-dose carbon monoxide | Health Technology |
Albumin Holding ApS
 Albumin Holding ApS Financial ConglomeratesFinance Functions as a financial holding companies | Finance |
Albumedix Ltd.
Albumedix Ltd. BiotechnologyHealth Technology Manufactures drugs, cell therapies and vaccines | Health Technology |
Lophora ApS |
